Michael R.L. Stratford

5.5k total citations
99 papers, 4.4k citations indexed

About

Michael R.L. Stratford is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael R.L. Stratford has authored 99 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 24 papers in Organic Chemistry and 22 papers in Oncology. Recurrent topics in Michael R.L. Stratford's work include Cancer, Hypoxia, and Metabolism (18 papers), Nitric Oxide and Endothelin Effects (9 papers) and Angiogenesis and VEGF in Cancer (9 papers). Michael R.L. Stratford is often cited by papers focused on Cancer, Hypoxia, and Metabolism (18 papers), Nitric Oxide and Endothelin Effects (9 papers) and Angiogenesis and VEGF in Cancer (9 papers). Michael R.L. Stratford collaborates with scholars based in United Kingdom, United States and Switzerland. Michael R.L. Stratford's co-authors include Peter Wardman, Madeleine F. Dennis, Lisa K. Folkes, Kantilal B. Patel, Luis P. Candeias, Steven A. Everett, Susan Galbraith, Matthew A. Naylor, Gillian M. Tozer and Patrick A. Riley and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael R.L. Stratford

99 papers receiving 4.3k citations

Peers

Michael R.L. Stratford
Lisa K. Folkes United Kingdom
John E. Biaglow United States
Ivan Spasojević United States
Bernd Epe Germany
Michaël Thomas United States
Cristina M. Furdui United States
Lisa K. Folkes United Kingdom
Michael R.L. Stratford
Citations per year, relative to Michael R.L. Stratford Michael R.L. Stratford (= 1×) peers Lisa K. Folkes

Countries citing papers authored by Michael R.L. Stratford

Since Specialization
Citations

This map shows the geographic impact of Michael R.L. Stratford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R.L. Stratford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R.L. Stratford more than expected).

Fields of papers citing papers by Michael R.L. Stratford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R.L. Stratford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R.L. Stratford. The network helps show where Michael R.L. Stratford may publish in the future.

Co-authorship network of co-authors of Michael R.L. Stratford

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R.L. Stratford. A scholar is included among the top collaborators of Michael R.L. Stratford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R.L. Stratford. Michael R.L. Stratford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grošelj, Blaž, Helen E. Scott, Judith Nicholson, et al.. (2017). Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity. Molecular Cancer Therapeutics. 17(2). 381–392. 29 indexed citations
2.
O’Connor, Liam, et al.. (2016). Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs. Nature Protocols. 11(4). 781–794. 66 indexed citations
3.
Al‐Assar, Osama, Martin-Immanuel Bittner, Serena Lunardi, et al.. (2016). The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells. Radiotherapy and Oncology. 119(2). 300–305. 11 indexed citations
4.
O’Connor, Liam, et al.. (2015). Efficient synthesis of 2-nitroimidazole derivatives and the bioreductive clinical candidate Evofosfamide (TH-302). Organic Chemistry Frontiers. 2(9). 1026–1029. 23 indexed citations
5.
Riley, Patrick A. & Michael R.L. Stratford. (2015). Oxidative calcium release from catechol. Bioorganic & Medicinal Chemistry Letters. 25(7). 1453–1454. 4 indexed citations
6.
Wong, Ping‐Pui, Fevzi Demircioglu, Essam Ghazaly, et al.. (2015). Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread. Cancer Cell. 27(1). 123–137. 183 indexed citations
7.
Kerr, Martin, Helen E. Scott, Blaž Grošelj, et al.. (2014). Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer. Clinical Cancer Research. 20(21). 5435–5445. 18 indexed citations
8.
Kelly, Matt, Emmanouil Fokas, Pavitra Kannan, et al.. (2014). Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia. Radiotherapy and Oncology. 111(1). 72–80. 36 indexed citations
9.
Qayum, Naseer, Jae Hong Im, Michael R.L. Stratford, et al.. (2011). Modulation of the Tumor Microvasculature by Phosphoinositide-3 Kinase Inhibition Increases Doxorubicin Delivery In Vivo. Clinical Cancer Research. 18(1). 161–169. 39 indexed citations
10.
Fokas, Emmanouil, Jae Hong Im, Sally A. Hill, et al.. (2011). Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature. Cancer Research. 72(1). 239–248. 112 indexed citations
11.
Stratford, Michael R.L. & Lisa K. Folkes. (2011). Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection. Journal of Chromatography A. 4 indexed citations
12.
Honess, Davina J., et al.. (2005). Pre-clinical development of DMU212, a cytochrome P450 CYP1A1 and CYP1B1-activated prodrug for targeted cancer therapy. Cancer Research. 65. 930–931. 1 indexed citations
13.
Davis, Peter D., Graeme J. Dougherty, David C. Blakey, et al.. (2002). ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.. Oxford University Research Archive (ORA) (University of Oxford). 62(24). 7247–53. 200 indexed citations
14.
15.
Everett, Steven A., K B Patel, Madeleine F. Dennis, et al.. (1998). Oxidative Denitrification of the Antitumour Drug Hydroxyguanidine. Free Radical Biology and Medicine. 24(1). 1–10. 6 indexed citations
16.
Everett, Steven A., Madeleine F. Dennis, Kantilal B. Patel, Michael R.L. Stratford, & Peter Wardman. (1996). Oxidative denitrification of Nω-hydroxy-l-arginine by the superoxide radical anion. Biochemical Journal. 317(1). 17–21. 18 indexed citations
17.
Parrick, John, et al.. (1994). Bioreductive Markers for Hypoxic Cells: 2-Nitroimidazoles with Biotinylated 1-Substituents. Journal of Medicinal Chemistry. 37(25). 4352–4356. 22 indexed citations
18.
Stratford, Michael R.L. & Madeleine F. Dennis. (1994). Determination of adenine nucleotides by fluorescence detection using high-performance liquid chromatography and post-column derivatisation with chloroacetaldehyde. Journal of Chromatography B Biomedical Sciences and Applications. 662(1). 15–20. 24 indexed citations
19.
Zackrisson, Björn, Lars Franzén, Roger Henriksson, et al.. (1994). Acute Effects of Accelerated Radiotherapy in Combination with Carbogen Breathing and Nicotinamide (Arcon). Acta Oncologica. 33(4). 377–381. 28 indexed citations
20.
Anderson, Robert F., Kantilal B. Patel, & Michael R.L. Stratford. (1985). The Influence of Thiols on the Pre-irradiation Incubation Effect of Nitroimidazoles in E. Coli Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 48(4). 485–494. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026